Sorrento Therapeutics, Inc. announced the unexpected passing of Mr. Najjam Asghar, Senior Vice President. Mr. Asghar died of apparent natural causes on January 6, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0145 USD | +31.82% | +61.11% | -88.26% |
04-10 | Sorrento Therapeutics, Inc. Emerged from Bankruptcy | CI |
03-15 | Scilex Settles Claims in Case Against Virpax for $6 Million, 6% Royalties From Three Drugs | MT |
1st Jan change | Capi. | |
---|---|---|
-88.26% | 7.88M | |
+10.77% | 114B | |
+10.36% | 105B | |
-4.61% | 23.83B | |
-0.82% | 21.73B | |
-10.12% | 18.1B | |
-42.12% | 16.34B | |
-16.81% | 16.13B | |
+2.48% | 13.75B | |
+32.44% | 11.76B |
- Stock Market
- Equities
- SRNE Stock
- News Sorrento Therapeutics, Inc.
- Sorrento Therapeutics, Inc. Announces Demise of Najjam Asghar, Senior Vice President